Forecast & Rating2 analysts currently cover Athira Pharma, of which 0 give a positive rating. The average price target is $4.00, about 40.7% downside from the current price of $6.75. Coverage is limited, so the data is for reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Nov 17, 2025Price forecast
$4.00-40.74%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met27.6%
Stock price$6.75
Avg. target$4.0
High target$4
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.